title: Histamine H1-receptor antagonistic drug olopatadine suppresses TSLP in atopic dermatitis model mice.
authors.forename: Mayumi
authors.initials: M
authors.lastname: Higashi
authors.forename: Ikuroh
authors.initials: I
authors.lastname: Ohsawa
authors.forename: Fumino
authors.initials: F
authors.lastname: Oda
authors.forename: Yuko
authors.initials: Y
authors.lastname: Yamada
authors.forename: Seiji
authors.initials: S
authors.lastname: Kawana
authors.forename: Kazumi
authors.initials: K
authors.lastname: Iida
authors.forename: Tsuyoshi
authors.initials: T
authors.lastname: Mitsuishi
mesh_terms: D000818:Animals; D016207:Cytokines / Q000037:antagonists & inhibitors* / Q000235:genetics*; D003876:Dermatitis, Atopic / Q000235:genetics*; D003990:Dibenzoxepins / Q000494:pharmacology*; D004195:Disease Models, Animal; D015870:Gene Expression / Q000187:drug effects; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D051379:Mice; D000069605:Olopatadine Hydrochloride; D000094632:Thymic Stromal Lymphopoietin
chemical_list: D016207:Cytokines; D003990:Dibenzoxepins; D006634:Histamine H1 Antagonists; D000069605:Olopatadine Hydrochloride; D000094632:Thymic Stromal Lymphopoietin; C000721967:TSLP protein, mouse